Please Wait

Applying Filters...

Gramicidin C
CEP/COS
Table View

Excipient Market Overview: Evonik launches high-purity excipients; India mandates disclosures from March 2026

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Gramicidin C

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

8 API Suppliers, 3 USDMF, 1 CEP/COS, 1 JDMF, 3 NDC API, 4 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

58 FDF Dossiers, 7 FDA Orange Book, 11 Europe, 31 Canada, 6 Australia, 3 South Africa

RELATED EXCIPIENT COMPANIES

2 Nanjing Well Pharmaceutical, 2 Kirsch Pharma, 7 Actylis, 10 BASF, 1 Esteem Industries, 2 Finar, 1 Gangwal Chemicals, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

12 Topical, 7 Solubilizers, 7 Parenteral, 6 Thickeners and Stabilizers, 4 Controlled & Modified Release, 4 Film Formers & Plasticizers, 2 Emulsifying Agents, 2 Granulation, 1 Surfactant & Foaming Agents, 1 Coating Systems & Additives, 1 Direct Compression